Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk

A common chemotherapy combined with a synthetic vitamin D analog eliminated actinic keratosis and decreased skin cancer risk for 3 years.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news